BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for ...
Fierce Healthcare

Hackensack Meridian Health partners with SpotitEarly to study cancer detection that pairs dogs with AI

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...
MarketersMEDIA Newsroom

Abdus Sobur Receives 2025 Global Recognition Award For AI-Driven Early Cancer Detection Research

Abdus Sobur receives a 2025 Global Recognition Award for developing artificial intelligence models that support earlier ...

Seeing thyroid cancer in a new light: When AI meets label-free imaging in the operating room

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.
Targeted Oncology

Blood-Based Colorectal Cancer Test Shows High Sensitivity in APLs

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
Orange County Business Journal

Helio Announces Partnership with National Clinic

Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...

Using AI to detect breast cancer in a safe and non-invasive manner

We combine affordable thermal cameras with advanced AI to analyse temperature maps of the human body without radiation, ...
Study Finds on MSN

Scientists discover early gene change in pancreatic cancer

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for early ...